The evolving role of axillary lymph node dissection in the modern era of breast cancer management

Surgical Oncology

Volumn 21, Issue 2, 2012, Pages 143-145

  Barry, J M ^a   Weber, W P ^a   Sacchini, V ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Axillary lymph node dissection; Positive sentinel lymph node management; Z0011 trial

Indexed keywords

EOSIN; HEMATOXYLIN; TAMOXIFEN;

ASPIRATION BIOPSY; AXILLARY LYMPH NODE EXTIRPATION; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; DIAGNOSTIC ACCURACY; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MICROMETASTASIS; PARTIAL MASTECTOMY; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; REVIEW; SENTINEL LYMPH NODE;

AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; SENTINEL LYMPH NODE BIOPSY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84860330496     PISSN: 09607404     EISSN: 18793320     Source Type: Journal    
DOI: 10.1016/j.suronc.2011.02.004     Document Type: Review

References (34)

1. D.N. Krag, D.L. Weaver, J.C. Alex, and J.T. Fairbank Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe Surg Oncol 2 6 1993 Dec 335 339
2. M.R. Kell, J.P. Burke, M. Barry, and M. Morrow Outcome of axillary staging in early breast cancer: a meta-analysis Breast Cancer Res Treat 120 2 2010 Apr 441 447
3. A.E. Giuliano, L. McCall, P. Beitsch, P.W. Whitworth, P. Blumencranz, and A.M. Leitch Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American college of surgeons oncology group Z0011 randomized trial Ann Surg 252 3 2010 Sep 432 433 426-32; discussion
4. M.C. Specht, J.V. Fey, P.I. Borgen, and H.S. Cody 3rd Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy? J Am Coll Surg 200 1 2005 Jan 10 14
5. M. Intra, N. Rotmensz, D. Mattar, O.D. Gentilini, A. Vento, and P. Veronesi Unnecessary axillary node dissections in the sentinel lymph node era Eur J Cancer 43 18 2007 Dec 2664 2668 Epub 2007 Oct 10
6. B.P. Baruah, A. Goyal, P. Young, A.G. Douglas-Jones, and R.E. Mansel Axillary node staging by ultrasonography and fine-needle aspiration cytology in patients with breast cancer Br J Surg 97 5 2010 May 680 683
7. A. Cyr, W.E. Gillanders, R.L. Aft, T.J. Eberlein, and J.A. Margenthaler Breast cancer in elderly women (≥80 years): variation in standard of care? J Surg Oncol 2010 Nov 23 [Epub ahead of print]
8. G. Martelli, P. Boracchi, M. De Palo, S. Pilotti, S. Oriana, and R. Zucali A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: results after 5 years of follow-up Ann Surg 242 1 2005 Jul 7 9 1-6; discussion
9. Y. Xing, M. Foy, D.D. Cox, H.M. Kuerer, K.K. Hunt, and J.N. Cormier Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer Br J Surg 93 5 2006 May 539 546
10. L.S. Dominici, V.M. Negron Gonzalez, A.U. Buzdar, A. Lucci, E.A. Mittendorf, and H.T. Le-Petross Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer Cancer 116 12 2010 Jun 15 2884 2889
11. B. Cady, M.D. Stone, and J. Wayne New therapeutic possibilities in primary invasive breast cancer Ann Surg 218 3 1993 Sep 338 347
12. U. Veronesi, R. Orecchia, S. Zurrida, V. Galimberti, A. Luini, and P. Veronesi Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapy Ann Oncol 16 3 2005 Mar 383 388
13. R.J. Gray, B. Mulheron, B.A. Pockaj, A. Degnim, and S.L. Smith The optimal management of the axillae of patients with microinvasive breast cancer in the sentinel lymph node era Am J Surg 194 6 2007 Dec 845 848
14. S. Yegiyants, L.M. Romero, P.I. Haigh, and L.A. DiFronzo Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node Arch Surg 145 6 2010 Jun 564 569
15. T. Onishi, H. Jinno, M. Takahashi, T. Hayashida, M. Sakata, and T. Nakahara Non-sentinel lymph node status and prognosis of breast cancer patients with micrometastatic sentinel lymph nodes Eur Surg Res 45 3-4 2010 Nov 22 344 349 [Epub ahead of print]
16. J. Rayhanabad, S. Yegiyants, K. Putchakayala, P. Haig, L. Romero, and L.A. Difronzo Axillary recurrence is low in patients with breast cancer who do not undergo completion axillary lymph node dissection for micrometastases in sentinel lymph nodes Am Surg 76 10 2010 Oct 1088 1091
17. W.C. Liang, B.J. Sickle-Santanello, and T.A. Nims Is a completion axillary dissection indicated for micrometastases in the sentinel lymph node? Am J Surg 182 4 2001 Oct 365 368
18. A.M. Naik, J. Fey, M. Gemignani, A. Heerdt, L. Montgomery, and J. Petrek The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 p.ocedures Ann Surg 240 3 2004 Sep 462 468
19. V.C. Tjan-Heijnen, and M. de Boer Minimal lymph node involvement and outcome of breast cancer. The results of the Dutch MIRROR study Discov Med 8 42 2009 Oct 137 139
20. M. de Boer, C.H. van Deurzen, J.A. van Dijck, G.F. Borm, P.J. van Diest, and E.M. Adang Micrometastases or isolated tumor cells and the outcome of breast cancer N Eng J Med 361 7 2009 Aug 13 653 663
21. D.M. Holwitt, W.E. Gillanders, R.L. Aft, T.J. Eberlein, and J.A. Margenthaler Sentinel lymph node biopsy in patients with multicentric/multifocal breast cancer: low false-negative rate and lack of axillary recurrence Am J Surg 196 4 2008 Oct 562 565
22. G. Cserni The reliability of sampling three to six nodes for staging breast cancer J Clin Pathol 52 9 1999 Sep 681 683
23. B. Fisher, J.H. Jeong, S. Anderson, J. Bryant, E.R. Fisher, and N. Wolmark Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation N Eng J Med 347 8 2002 Aug 22 567 575
24. M. Clarke, R. Collins, S. Darby, C. Davies, P. Elphinstone, E. Evans Early Breast Cancer Trialists' Collaborative Group (EBCTCG) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Lancet 366 9503 2005 Dec 17 2087 2106
25. Y. Andersson, J. Frisell, M. Sylvan, J. de Boniface, and L. Bergkvist Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes J Clin Oncol 28 17 2010 Jun 10 2868 2873 Epub 2010 May 10
26. D.N. Krag, S.J. Anderson, T.B. Julian, A.M. Brown, S.P. Harlow, and J.P. Costantino Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial Lancet Oncol 11 10 2010 Oct 927 933
27. N. Fujimoto, A. Amemiya, M. Kondo, A. Takeda, and N. Shigematsu Treatment of breast carcinoma in patients with clinically negative axillary lymph nodes using radiotherapy versus axillary dissection Cancer 101 10 2004 Nov 15 2155 2163
28. J. Park, J.V. Fey, A.M. Naik, P.I. Borgen, K.J. Van Zee, and H.S. Cody 3rd A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram Ann Surg 245 3 2007 Mar 462 468
29. C.H. Neal, C.P. Daly, A.V. Nees, and M.A. Helvie Can preoperative axillary US help exclude N2 and N3 metastatic breast cancer? Radiology 257 2 2010 Nov 335 341
30. A. Gil-Rendo, G. Zornoza, M.J. García-Velloso, F.M. Regueira, C. Beorlegui, and M. Cervera Fluorodeoxyglucose positron emission tomography with sentinel lymph node biopsy for evaluation of axillary involvement in breast cancer Br J Surg 93 6 2006 Jun 707 712
31. A. Recht, S.B. Edge, and L.J. Solin Postmastectomy radiotherapy: clinical practice guidelines of the American society of clinical oncology J Clin Oncol 19 2001 1539 1569
32. G.H. Lyman, A.E. Giuliano, M.R. Somerfield, A.B. Benson 3rd, D.C. Bodurka, H.J. Burstein American Society of Clinical Oncology American society of clinical oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer J Clin Oncol 23 30 2005 Oct 20 7703 7720
33. K.K. Swenson, A. Mahipal, M.J. Nissen, T.M. Tuttle, K. Heaton, and R.M. Lally Axillary disease recurrence after sentinel lymph node dissection for breast carcinoma Cancer 104 9 2005 Nov 1 1834 1839
34. S. Zakaria, G. Pantvaidya, C.A. Reynolds, C.S. Grant, S. Sterioff, and J.H. Donohue Sentinel node positive breast cancer patients who do not undergo axillary dissection: are they different? Surgery 143 5 2008 May 641 647 Epub 2008 Feb 13